Obesity, metabolic syndrome and diabetes are disease states that share a number of molecular mechanism interrelationships. The causes of these diseases may be attributed to interactions among multiple genes, cellular signaling pathways and environmental factors denoting their dynamic and complex entanglements. BioVision continuously monitors new discoveries in the fields of diabetes and obesity research and is dedicated to providing the research community with the latest, high quality research tools to further elucidate gene product participation and inter-pathway associations for these disease states. As a new addition to our pipeline, BioVision is pleased to add nineteen (19) new ELISA Assay Kits which encompass adipokines (NAMPT, Vaspin, Resistin and RBP4), adiposity and glucose tolerance (NQO1), Obesity (FTO and CTRP5), insulin resistance and sensitivity (SIRT1 and SIRT2), angiogenesis (ANGPTL3, ANGPTL6) and obesity-related hypertension (ACE2).
|
Nampt (Visfatin/PBEF; mouse/rat; Dual ELISA)
|
|
|
Nampt (Visfatin/PBEF; human; intracellular; ELISA)
|
|
|
Nampt (Visfatin/PBEF; mouse/rat; intracellular; Dual ELISA)
|
|
|
RBP4 (human; competitive; ELISA)
|
|
|
RBP4 (human; ELISA; Quantitative)
|
|
|
RBP4 (mouse/rat; Dual ELISA)
|
|
|
ANGPTL3 (human; ELISA)
|
|
|
ANGPTL3 (mouse/rat; Dual ELISA)
|
|
|
ANGPTL6 (human; ELISA)
|
|
|
Vaspin (human; ELISA)
|
|
|
ACE2 (human; ELISA)
|
|
|
Resistin (human; ELISA)
|
|
|
Resistin (mouse; ELISA)
|
|
|
FTO (human; intracellular; ELISA)
|
|
|
FTO (mouse; intracellular; ELISA)
|
|
|
Sirtuin 1 (human; intracellular; ELISA)
|
|
|
Sirtuin 2 (human; intracellular; ELISA)
|
|
|
CTRP5 (human; competitive; ELISA)
|
|
|
NQ01 (human; intracellular; ELISA)
|
